| Kaitlyn Ann Gregory, OD | |
|
603 Nashua St, Milford, NH 03055-5041 | |
| (603) 672-0338 | |
| (602) 672-5228 |
| Full Name | Kaitlyn Ann Gregory |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 6 Years |
| Location | 603 Nashua St, Milford, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063901619 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT1001 (Maine) | Secondary |
| 152W00000X | Optometrist | 0980 (New Hampshire) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Myeyedr Optometry Of New Hampshire Pllc | 2961810981 | 20 |
News Archive
The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.
A new review article investigates the clinical and viral characteristics, pathogenesis, as well as human genetic basis associated with COVID-19.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.
Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer's hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the main ingredient of the plaque lesions that are a hallmark of Alzheimer's.
› Verified 2 days ago
| Provider Name | Barrington Family Eyecare Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225281421 PECOS PAC ID: 5193872760 Enrollment ID: O20090416000657 |
News Archive
The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.
A new review article investigates the clinical and viral characteristics, pathogenesis, as well as human genetic basis associated with COVID-19.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.
Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer's hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the main ingredient of the plaque lesions that are a hallmark of Alzheimer's.
› Verified 2 days ago
| Provider Name | Myeyedr Optometry Of New Hampshire Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1730764754 PECOS PAC ID: 2961810981 Enrollment ID: O20210412002458 |
News Archive
The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.
A new review article investigates the clinical and viral characteristics, pathogenesis, as well as human genetic basis associated with COVID-19.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.
Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer's hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the main ingredient of the plaque lesions that are a hallmark of Alzheimer's.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlyn Ann Gregory, OD 1950 Old Gallows Rd Ste 520, Vienna, VA 22182-3970 Ph: (703) 847-8899 | Kaitlyn Ann Gregory, OD 603 Nashua St, Milford, NH 03055-5041 Ph: (603) 672-0338 |
News Archive
The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.
A new review article investigates the clinical and viral characteristics, pathogenesis, as well as human genetic basis associated with COVID-19.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.
Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer's hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the main ingredient of the plaque lesions that are a hallmark of Alzheimer's.
› Verified 2 days ago
Dr. Suzanna Mary Schmitt, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 577nashua St, Milford, NH 03055 Phone: 603-672-0338 Fax: 602-672-5228 | |
Dr. Sharon Grove Perkins, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 81 Mont Vernon Rd, Milford, NH 03055 Phone: 603-673-1330 | |
Philip S Aubrey Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 81 Mont Vernon Street, Milford, NH 03055 Phone: 603-673-1330 | |
Dr. Joseph Raczek, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 577 Nashua St, Milford, NH 03055 Phone: 603-672-0338 Fax: 602-672-5228 | |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 577 Nashua St, Milford, NH 03055 Phone: 603-672-0338 Fax: 602-672-5228 | |
Dr. Philip Aubrey, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 81 Mont Vernon Rd, Milford, NH 03055 Phone: 603-673-1330 Fax: 603-673-7007 |